Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2008

View Archived Issues

Genetic studies find link to lung cancer

Medarex to continue with phase III trial of ipilimumab in advanced melanoma

Phase I clinical study in HIV to use Crucell's recombinant adenovirus serotype 26 vector

Department of Defense awards contract to Cleveland BioLabs to develop Protectan

OxThera completes enrollment in pivotal study of Oxabact in primary hyperoxaluria

Pharmaxis reports positive phase II data for Bronchitol in cystic fibrosis

Abbott launches Zemplar capsules in the U.K.

VIA provides safety update for VIA-2291 ongoing phase II clinical program

In vivo efficacy of BMS-641988, a novel androgen receptor antagonist

Vitreoretinal enrolls patients in phase III Vitreosolve trial for diabetic retinopathy

First preterm infant is enrolled in phase II clinical study of Kiobrina

Clavis initiates recruitment in phase II clinical study of Elacyt in hematological cancers

MMRF awards USD 2.25 million to three universities for proteomics research in myeloma

Biomatrix signs letter of intent with Vibragene to perform genetic testing for biomarkers

Genfit updates sanofi-aventis collaboration programs

Indevus and Orion sign license agreement for Vantas in prostate cancer

Human ApoB-100 related peptide vaccine effects modulated by dose, diet timing

Intravitreal JSM-6427 well tolerated in age-related macular degeneration patients

Hana starts phase I topical menadione trial for EGFR inhibitor-associated rash

Lower strength Kaletra tablet for pediatric use approved in Europe

Improved pharmacokinetics of second-generation FBPase inhibitor for the treatment of diabetes

MediGene reports clinical efficacy data for EndoTAG-1 in pancreatic carcinoma

Vivus enters funding collaboration with Deerfield for erectile dysfunction

New agents for HIV infection reported in recent Osaka University patent

Novel antiglaucoma agents disclosed in recent Allergan patent

New treatment option for Alzheimer's disease imparted in recent Merck & Co. and Sunesis patent

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...